Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Mutations predict response to pembrolizumab across multiple tumour types

Two-year study shows efficacy of immunotherapy drug in 12 mismatch-repair deficient cancers that failed to respond to prior treatment.

Several markers have been identified that can predict response to the immunotherapy pembrolizumab in specific tumour types. But a universal marker across all tumour types has not been established.

In research published in Science[1] (8 June 2017), a team enrolled 86 patients with 12 different cancer types whose disease had progressed despite previous treatment to receive pembrolizumab for up to two years. All the patients had mismatch-repair (MMR) deficiencies, meaning they had mutations in genes involved in repairing DNA errors.

The team found that 66 (77%) of the 86 patients (95% confidence interval, 66–85%) achieved disease control for at least 12 weeks, including 18 (21%) patients who had a complete response.

Given that tests for MMR-deficiency are already available, the researchers predict that in future it will become standard to test for MMR deficiency in patients with refractory cancer, regardless of tumour type.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20203057

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Developing Your Prescribing Skills

    Developing Your Prescribing Skills

    Developing Your Prescribing Skills uses case studies, mind maps and feedback from experienced prescribers. It supplies practical advice on the issues facing prescribers in all types of practice.

    £22.00Buy now
  • Workplace Drug Testing

    Workplace Drug Testing

    Explains drug testing regulatory frameworks and all aspects of drug analysis. Case studies of successful programmes are included.

    £79.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £42.00Buy now
  • Remington Education: Pharmaceutics

    Remington Education: Pharmaceutics

    Case studies and MCQs explaining the pharmaceutics behind drug delivery.

    £32.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £24.00Buy now
  • FASTtrack: Complementary and Alternative Medicine

    FASTtrack: Complementary and Alternative Medicine

    A quick-start guide to all the main types of Complementary and Alternative Medicine, providing both theoretical and practical information.

    £24.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Close up of DNA genome sequence

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.